PROPHILAXIS OF CATARACTOGENESIS AFTER VITRECTOMY
To evaluate the efficacy of plastoquinonyldecyltriphenylphosphonium bromide (Visomitin®) in cataract prevention or cataract progression after vitrectomy. Study involved 60 subtotal haemophthalmus patients before and aftervitrectomy. In the 1-group (30 people, 30 eyes) patientsreceived Vizomitin® instillations (in addition to standard postoperative therapy; 3 times per day), in the 2-group only standard treatment was given. The frequency (percentage) of the initial opacities of the lens and the dynamics of the intensity of the initial opacities of the lens (according to the LOCS III classification) in both groups were evaluated before the vitrectomy and 6 months after the operation. The initial cataract development was noted in 33.3 % of patients in the 2-group and in 3.3 % of patients in the 1-group, the difference was statistically significant. In 2-group patients there was a significant increase in the intensity of opacities of the lens. The increase of lens opacities intensity in 1-group was statistically insignificant. Plastoquinonyldecyltriphenylphosphonium bromide (Visomitin®) was effective in preventing the development and progression of cataracts after vitrectomy.